Community Health Azithromycin Trial in Burkina Faso

PHASE4CompletedINTERVENTIONAL
Enrollment

77,664

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Childhood Mortality
Interventions
DRUG

Azithromycin

biannual azithromycin in eligible communities to children 1 to 59 months old Targeted azithromycin to children aged 5 to 8 weeks old at the vaccine visit

DRUG

Placebos

biannual placebo in eligible communities to children 1 to 59 months old Targeted placebo to children aged 5 to 8 weeks old at the vaccine visit

Trial Locations (1)

Unknown

Centre de Recherche en Sante de Nouna, Nouna

All Listed Sponsors
collaborator

Centre de Recherche en Sante de Nouna, Burkina Faso

OTHER_GOV

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

University of California, San Francisco

OTHER

NCT03676764 - Community Health Azithromycin Trial in Burkina Faso | Biotech Hunter | Biotech Hunter